Keytruda Market Trends: Immunotherapy Advancements Driving Global...

aggiunto articolo blog Health

2026-03-22 18:29:05 -

Keytruda Market Trends: Immunotherapy Advancements Driving Global Demand

The global Keytruda market is witnessing substantial expansion, driven by the increasing prevalence of cancer and the growing adoption of immunotherapy in oncology treatment. Keytruda (pembrolizumab), a PD-1 inhibitor developed for multiple cancer indications, has transformed cancer care by enabling the immune system to detect and attack tumor cells more effectively. According to...

0 Commenti 0 Condivisioni 59 Visualizzazioni